Targeted in vivo Micro Platform for Nanodevices
Targeted in vivo Micro Platform for Nanodevices
批准号:
7067840
负责人:
Roger tsien
金额:
$26.16万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2010-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A group of investigators with complementary expertise has been assembled to construct micron-sized
devices ("mother ships") that are equipped with nano-sized features and that are capable of homing into
cancerous tumors in vivo and performing various tasks in the tumor. These tasks include detecting,
identifying, and imaging a tumor, performing measurements on it, and delivering therapies. The system
will be based on micron-sized, nanostructured porous particles composed primarily of silicon or silicon
oxides. The mother ship design concept and silicon-based scaffolding were chosen for a number of
reasons: (1) The micron-range size makes it possible to use silicon while retaining its unique engineering
features such as optical and radiofrequency reporting properties, high-capacity nano-porous carrier
structure, biocompatibility and bioresorbability; (2) This applicant group has extensive experience with
nanostructured silicon microdevices, and prototype mother ship particles resembling red blood cells have
already been constructed and tested in-vivo; (3) Preliminary results suggest that micron-sized particles
coated with tumor-specific vascular homing peptides become lodged in tumor vasculature; (4) Micronsized
particles, unlike nanoparticles, are not taken up by the reticuloendothelial system; (5) The mother
ship can be extensively
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金